Correlation Between Prognosis and Response to Treatment in Children with FSGS
,
Abstract
To determine the prognostic value of response to treatment in patients with focal segmental glomerulo-sclerosis. FSGS includes 10-15% of idiopathic Nephrotic syndrome in children. Bulk of evidence supports disease relationship with immune system. Unfortunately, responses to immunosuppressive drugs are not desirable and progression to end-stage renal disease is common. We analyzed 62 out of 99 cases of biopsy proven idiopathic FSGS who were followed for at least 5-years or until renal failure occurred during study. Study design was historical cohort and patients were divided into two groups: exposed (resistant to treatment) and non-exposed (responsive to treatment). Correlation between prognosis and response to treatment was statistically evaluated. P-value (0.05 and relative risk ( 1 was considered significant. In 3 out of 25 steroid responsive patients (12%) and 22 out of 37 steroid resistant patients (59.5%), disease progressed to renal failure. Disease progressed to renal failure in 2 out of 11 cyclophosphamide responsive patients (18.1%), 17 out of 23 cyclophosphamide resistant patients (74.3%), and 8 out of 14 cyclosporine resistant patients (57.1%). 2 patients who responded to cyclosporine had normal renal function at the time of the last follow up. We concluded that favorable response to steroid and cyclophosphamide treatment is a protective factor against disease progression to end stage renal disease and resistance to these drugs imply a poor prognosis. For making any definite conclusion concerning response to cyclosporine treatment and prognosis, similar studies with a larger sample are required.
Hara M, Yanagihara T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 2001;89(3): 342-7.
Raats CJ, van den Born J, Berden JH. Glomerular heparin sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int 2000, 57: 385-400.
Niaudet P. Steroid-resistant idiopathic nephrotic syndrome in children. In: Niaudet P, Avner ED, Harmon WE, editors. Pediatric Nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 557-73.
Habib R. Editorial: Focal glomerular sclerosis. Kidney Int 1973; 4(6): 355-61.
Habib R, Kleinknecht C. The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol Annu 1971; 6: 417-74.
Churg J, Habib R, White RH. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 1970; 760(1): 1299-302.
Jenis EH, Teichman S, Briggs WA, Sandler P, Hollerman CE, Calcagno PL, et al. Focal segmental glomerulosclerosis. Am J Med 1974; 57(5): 695-705.
Mathis BJ, Kim SH, Calabrese K, Haas M, Seidman JG, Seidman CE, et al. A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13. Kidney Int 1998; 53(2): 282-6.
Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, et al. Mutations in ACTN4, encoding alphaactinin- 4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24(3): 251-6.
Winn MP, Conlon PJ, Lynn KL, Howell DN, Gross DA, Rogala AR, et al. Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis. Kidney Int 1999; 55(4): 1241-6.
Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990; 4(4): 303-7.
Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA. et al. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 1995; 43(2): 84-8.
Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A. Aggressive, long-term cyclosporine therapy for steroidresistant focal segmental glomerulosclerosis. J Am Soc Nephrol 1995; 5(10): 1820-5.
Lieberman KV, Tejani A. A randomized double-blind placebo- controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996; 7(1): 56-63.
Geary DF, Farine M, Thorner P, Baumal R. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 1984; 22(3): 109-13.
Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome [editorial]. Clin Nephrol 1991; 35 Suppl 1: S48-60.
Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 1991; 5(4): 393-7.
Kashgarian M, Hayslett JP, Siegel NJ. Lipoid nephrosis and focal sclerosis distinct entities or spectrum of disease. Nephron 1974; 13(2): 105-8.
Habib R. Editorial: Focal glomerular sclerosis. Kidney Int 1973; 4(6): 355-61.
Niaudet P. Steroid-resistant idiopathic nephrotic syndrome in children. In: Niaudet P, Avner ED, Harmon WE, editors. Pediatric Nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 543-56.
Paik KH, Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, et al. Primary focal segmental glomerular sclerosis in children: clinical course and prognosis. Pediatr Nephrol 2007; 22(3): 389-95.
Hafeez F, Ahmad TM, Anwar S. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome. J Coll Physicians Surg Pak 2005; 15(6): 329-32.
Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G Jr, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB Jr. Treatment of steroidresistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review. J Nephrol 2005; 18(6): 711-20.
Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome. Indian Pediatr 2006; 43(1): 14-9.
Martinelli R, Okumura AS, Pereira LJ, Rocha H. Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 2001; 16(8): 658-61.
Niaudet P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr 1994; 125(6 Pt 1): 981-6.
| Files | ||
| Issue | Vol 47, No 2 (2009) | |
| Section | Original Article(s) | |
| Keywords | ||
| Children nephrotic syn FSGS steroid responsive steroid resistant prognosis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
